Manufacturer agreements tying drugs together must be explained within 30 days
What the document says“not later than 30 days after the finalization of any contract or agreement between such pharmacy benefit manager or an affiliate of such pharmacy benefit manager and a manufacturer”
Within 30 days of finalizing an agreement with a manufacturer that makes rebates, discounts, payments or other financial incentives on one drug contingent on coverage, formulary placement or utilization management conditions on other drugs, the manager must give the sponsor a written explanation. It must name the manufacturer and all drugs covered, describe the terms at a high level, and be certified by the manager's Chief Executive Officer, Chief Financial Officer or General Counsel, or by someone reporting directly to one of them.
What the document actually says“not later than 30 days after the finalization of any contract or agreement between such pharmacy benefit manager or an affiliate of such pharmacy benefit manager and a manufacturer”
The middleman has 30 days after a deal with a drug maker is signed. Then it must explain that deal in writing.
Some deals tie one drug to another. Money on one turns on how the plan treats the rest. The plan needs to know that is happening.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.